Evaluation of A-DIVA Score Effectiveness at Admission for Preserving Venous Capital in Patients With Difficult Access
ERV-ADIVA
Randomized Controlled Clinical Trial Assessing the Effectiveness of a Venipuncture Strategy Adapted According to A-DIVA Score Results Compared to Standard Care in Reducing the Number of Punctures
1 other identifier
interventional
600
1 country
1
Brief Summary
In certain cases (e.g.: patient who are difficult to perfuse, thin veins, etc.), an increase in venipunctures performed by study nurses in healthcare services can lead to a loss of venous capital, repeated pain during punctures, discontinuous treatment follow-up and numerous requests for assistance from colleagues, including nurse anesthetists, but often too late. The main objective of project is to reduce the number of punctures to access the venous system after evaluation of adult patients upon entering the hospitalization department using the A-DIVA tool. the A-DIVA score predicts the difficulty in infusing an adult patient
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Apr 2025
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 4, 2025
CompletedStudy Start
First participant enrolled
April 21, 2025
CompletedFirst Posted
Study publicly available on registry
May 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
September 1, 2028
May 1, 2025
April 1, 2025
2.9 years
February 4, 2025
April 28, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Number of Venipunctures Performed to Establish the First Peripheral Intravenous Line in the Hospital services
Number of Venipunctures Performed to Establish the First Peripheral Intravenous Line in the Hospital services
Periprocedural Venipuncture performed by study nurse from Day 0 (date of admission to hospital service) to Day 10 or until hospital discharge subject
Secondary Outcomes (2)
pain score (numeric rating scale) during venipuncture
During venipuncture from Day 0 to Day 10 or throughout the entire hospitalization period
duration of successful catheter placement
During catheter placement from Day 0 to Day 10 or throughout the entire hospitalization period
Study Arms (2)
with Adult-Difficult IntraVenous Access (A-DIVA) and with A-DIVA modified score evaluation
EXPERIMENTALintravenous access of these patients will be evaluated by the ADIVA and with modified ADIVA (ADIVA m) scores before puncture by the nurse
without Adult-Difficult IntraVenous Access (A-DIVA) score evaluation
NO INTERVENTIONcontrol group, patients will not undergo an evaluation of their intravenous access using the Adult-Difficult IntraVenous Access (A-DIVA) tool prior to peripheral IV catheter placement. They will receive standard care as routinely provided in the hospital.
Interventions
The patient's intravenous access will be evaluated using the A-DIVA score by the study nurse at the time of admission, prior to venipuncture performed by the care nurse
The patient's intravenous access will be evaluated using the A-DIVA-m score by the study nurse at the time of admission, prior to venipuncture performed by the care nurse
Eligibility Criteria
You may qualify if:
- Male and Female Adult Patients Aged 18 Years and Older
- written informed consent given by patient
- Affiliation to a social security system or equivalence system
You may not qualify if:
- Patients in Intensive Care Units
- Patients with Psychiatric Disorders or Under Psychiatric Care
- Minor Patients Under 18 Years of Age
- Pregnant or Breastfeeding Women
- Vulnerable and Protected Individuals as Defined by the Public Health Code (Articles L.1121-5 to L.1121-8 and L.1122-1-2)
- Patients Participating in Another Interventional Study
- Dying patients
- Patients Receiving Infusions of:
- Chemotherapy Drugs with a pH \<5 or \>8
- Solutions with an Osmolarity \>900 mOsm/L
- Patients refusing to participate in the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
CHI Robert Ballanger
Aulnay-sous-Bois, 93602, France
Related Publications (3)
Yen K, Riegert A, Gorelick MH. Derivation of the DIVA score: a clinical prediction rule for the identification of children with difficult intravenous access. Pediatr Emerg Care. 2008 Mar;24(3):143-7. doi: 10.1097/PEC.0b013e3181666f32.
PMID: 18347490BACKGROUNDHeydinger G, Shafy SZ, O'Connor C, Nafiu O, Tobias JD, Beltran RJ. Characterization of the Difficult Peripheral IV in the Perioperative Setting: A Prospective, Observational Study of Intravenous Access for Pediatric Patients Undergoing Anesthesia. Pediatric Health Med Ther. 2022 May 4;13:155-163. doi: 10.2147/PHMT.S358250. eCollection 2022.
PMID: 35548373BACKGROUNDvan Loon FHJ, van Hooff LWE, de Boer HD, Koopman SSHA, Buise MP, Korsten HHM, Dierick-van Daele ATM, Bouwman ARA. The Modified A-DIVA Scale as a Predictive Tool for Prospective Identification of Adult Patients at Risk of a Difficult Intravenous Access: A Multicenter Validation Study. J Clin Med. 2019 Jan 26;8(2):144. doi: 10.3390/jcm8020144.
PMID: 30691137BACKGROUND
Study Officials
- PRINCIPAL INVESTIGATOR
Eric MORTUREUX, IADE
CH BALLANGER
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 4, 2025
First Posted
May 1, 2025
Study Start
April 21, 2025
Primary Completion (Estimated)
March 1, 2028
Study Completion (Estimated)
September 1, 2028
Last Updated
May 1, 2025
Record last verified: 2025-04
Data Sharing
- IPD Sharing
- Will not share